Log in to search using one of your social media accounts:

 

These Are the Dirtiest Places in Your Hotel Room
You may want to pack some disinfectant wipes the next time you travel. When you stay in a hotel room, you usually expect that staff have cleaned it thoroughly after the last guest stayed there. But this is not always the case, and even regular cleaning can leave travelers open to other people’s germs, experts say. In one 2012 study presented at the general meeting of the American Society of Microbiology, 81% of surfaces sampled had some fecal bacteria. Researchers found that light switches and TV remotes were among the objects most heavily contaminated with bacteria, and toilets and bathroom sinks also had high level...
Source: TIME: Health - February 13, 2018 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Germs healthytime onetimetravel Source Type: news

Use of cholera vaccines expands, raising hopes
(Source: ScienceNOW)
Source: ScienceNOW - February 8, 2018 Category: Science Authors: Kupferschmidt, K. Tags: Epidemiology, Medicine, Diseases, Virology In Depth Source Type: news

Could the Deadly 1918 Flu Pandemic Happen Again?
It's "100 percent" certain that another global flu crisis will happen, said Dr. Greg Poland, a virologist and vaccine researcher with the Mayo Clinic in Rochester, Minn. (Source: WebMD Health)
Source: WebMD Health - February 7, 2018 Category: Consumer Health News Source Type: news

Ketogenic diets could slow aging research suggests
Researchers from the  Gladstone Institute for Virology and Immunology in San Francisco found carbohydrate 'starvation' causes the body to release a chemical that protects cells from 'internal stress'. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2018 Category: Consumer Health News Source Type: news

2 Novan execs out as company pushes to broaden focus
As Morrisville-based Novan (Nasdaq: NOVN) continues to execute on a broadened focus, the company is also seeing a pair of C-suite executives depart.   Novan said Thursday that it’s gotten underway with a Phase 2 clinical trial for its product candidate SB206 for the treatment of a viral skin infection known as molluscum, which falls in line with its previously announced pivot from a primary focus on acne to virology and immunology. The clin ical trial announcement closely follows two filings with… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 25, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Critics see only risks, no benefits in horsepox paper
(Source: ScienceNOW)
Source: ScienceNOW - January 25, 2018 Category: Science Authors: Kupferschmidt, K. Tags: Genetics, Microbiology, Pharmacology, Toxicology, Virology In Depth Source Type: news

Dolutegravir-Rilpivirine Effective for Maintaining HIV Suppression Dolutegravir-Rilpivirine Effective for Maintaining HIV Suppression
The recently approved combination of dolutegravir and rilpivirine is effective for maintaining virological suppression in adults with HIV-1, according to results from the SWORD-1 and SWORD-2 noninferiority studies.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 23, 2018 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Switch From Ritonavir to Cobicistat in HIV With Dyslipidemia Switch From Ritonavir to Cobicistat in HIV With Dyslipidemia
A new study examines the impact of switching from ritonavir to cobicistat on lipid parameters among virologically suppressed HIV-infected patients with dyslipidemia.HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2018 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Health Highlights: Jan. 17, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: AIDS Activist Dr. Mathilde Krim Dies at 91 Dr. Mathilde Krim, an American geneticist and virologist who was a leader in the fight against... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 17, 2018 Category: General Medicine Source Type: news

In Pakistan, surveillance for polio reveals a paradox
(Source: ScienceNOW)
Source: ScienceNOW - January 11, 2018 Category: Science Authors: Roberts, L. Tags: Asia/Pacific News, Epidemiology, Medicine, Diseases, Virology In Depth Source Type: news

Study Backs Hepatitis C Treatment in Injection Drug Users
Use of sofosbuvir-velpatasvir to treat hepatitis C virus (HCV) infection in injection drug users usually leads to a sustained virologic response at 12 weeks... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 8, 2018 Category: Primary Care Source Type: news

Nigeria:Expert Calls for Increased Funding to Tackle Drug-Resistant Tuberculosis
[This Day] Abuja -The Associate Director, Global Fund Programmes, Institute of Human Virology Nigeria (IHVN), Dr. Aderonke Agbaje, has called on the government to support the drug-resistant tuberculosis programme in the country with funds as donor funding for the disease has reduced significantly. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - December 21, 2017 Category: Infectious Diseases Source Type: news

Toolkit: State Strategies to Improve Health Outcomes for People Living with HIV
This toolkit is intended provide state officials with tools and resources, including issue briefs, webinars, and presentations, they need to improve rates of sustained virologic suppression of HIV. New items will be added to the toolkit on a regular basis, providing state officials with up-to-date information and timely policy resources. (Source: PHPartners.org)
Source: PHPartners.org - December 19, 2017 Category: International Medicine & Public Health Source Type: news

Dr Max Pemberton: Is the flu jab a waste of time?
There are three main types of flu virus — A, B and C — and hundreds of different subtypes, explains John Oxford, professor of virology at Queen Mary University of London. (Source: the Mail online | Health)
Source: the Mail online | Health - December 8, 2017 Category: Consumer Health News Source Type: news

Ethnic Disparities in Progression and Survival in Chronic HCV Ethnic Disparities in Progression and Survival in Chronic HCV
This study evaluated differences in the natural history of chronic HCV infection in different ethnic groups. Does a sustained virological response impact disparities?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Press invitation to Europe's largest congress on hepatology
(European Association for the Study of the Liver) The International Liver Congress ™ (ILC) is the annual EASL meeting, and the flagship event in EASL's educational calendar. Every year in April, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging come together from around the world to learn about the latest in liver research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2017 Category: International Medicine & Public Health Source Type: news

HCC in Chronic HBV vs Chronic HCV After Virologic Response HCC in Chronic HBV vs Chronic HCV After Virologic Response
Does the achievement of virologic response modify the risk of hepatocellular carcinoma differently in patients with chronic hepatitis B as compared to those with chronic hepatitis C?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Janssen Announces U.S. FDA Approval of First and Only Complete, Single-Pill, Two-Drug Regimen, JULUCA ® (Dolutegravir and Rilpivirine), for the Treatment of HIV-1 Infection
Provides New Treatment Option for Stable, Virologically Suppressed Adults Living with HIV-1 (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 22, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Juluca (dolutegravir and rilpivirine) for the Maintenance Treatment of Virologically Suppressed HIV-1 Infection
November 21, 2017 -- The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 21, 2017 Category: Drugs & Pharmacology Source Type: news

Rapid Risk Assessment: Outbreaks of Highly Pathogenic Avian Influenza A(H5N8) in Europe
European Union, European Centre for Disease Prevention and Control. 11/18/2016 This nine-page report summarizes the epidemiological, virological, and environmental information relating to outbreaks of highly pathogenic avian influenza A virus subtype A(H5N8) in Europe up to November 15, 2016, and assesses the risk to public health in European Union/European Economic Area (EU/EEA) countries associated with the outbreak. It concludes that the risk of zoonotic transmission to the general public in EU/EEA countries is considered to be very low. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - November 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Increasing Rates of Virologic Suppression: Promising Practices from HIV Health Improvement Affinity Group States
December 6, 2017 2:30-4:00pm ET.(HIV Health Improvement Affinity Group) (Source: PHPartners.org)
Source: PHPartners.org - November 8, 2017 Category: International Medicine & Public Health Source Type: news

4-in-1 flu shot may mean lifelong protection against the flu
(University of Nebraska-Lincoln) Scientists with the Nebraska Center for Virology find a vaccine combining centralized ancestral genes from four major influenza strains could be a path toward a universal flu shot. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 2, 2017 Category: International Medicine & Public Health Source Type: news

Better Together: How Cross-Agency Data Sharing Can Improve the Care Continuum for People Living with HIV/AIDS
Georgia has leveraged an existing data use agreement (DUA) to gather data across agencies and is using that data to target key improvements to improve rates of virologic suppression in HIV-infected, Medicaid beneficiaries. (Source: PHPartners.org)
Source: PHPartners.org - October 31, 2017 Category: International Medicine & Public Health Source Type: news

Single-tablet Switch Option Effective in Virologically Suppressed HIV Single-tablet Switch Option Effective in Virologically Suppressed HIV
A new single-tablet regimen (STR) that includes the protease inhibitor (PI) darunavir, cobicistat, emtricitabine, and tenofovir alafenamide maintains viral suppression in adults infected with HIV-1, according to results from the EMERALD phase 3 noninferiority trial.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - October 20, 2017 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Glecaprevir-Pibrentasvir Effective in Patients With HCV, CKD Glecaprevir-Pibrentasvir Effective in Patients With HCV, CKD
Glecaprevir-pibrentasvir produced high sustained virologic response rates regardless of the underlying HCV genotype in patients with severe chronic kidney disease and HCV infection, a study found.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Sustained Response with HCV Combo Drug in CKD
(MedPage Today) -- Patients with both diseases had virologic response and no failure (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 12, 2017 Category: Gastroenterology Source Type: news

Investigational Flu Drug a Near Match for Oseltamivir
(MedPage Today) -- Clinical outcomes'identical'but virology different (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 8, 2017 Category: Primary Care Source Type: news

Broadly neutralizing antibodies to prevent HIV-1
(Source: ScienceNOW)
Source: ScienceNOW - October 5, 2017 Category: Science Authors: Cohen, M. S., Corey, L. Tags: Immunology, Medicine, Diseases, Virology perspective Source Type: news

Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site. Trispecific Abs exhibited higher potency and breadth than any previously described single bnAb, showed pharmacokinetics similar to those of human bnAbs, and conferred complete immunity against a mixture of simian-human immuno...
Source: ScienceNOW - October 5, 2017 Category: Science Authors: Xu, L., Pegu, A., Rao, E., Doria-Rose, N., Beninga, J., McKee, K., Lord, D. M., Wei, R. R., Deng, G., Louder, M., Schmidt, S. D., Mankoff, Z., Wu, L., Asokan, M., Beil, C., Lange, C., Leuschner, W. D., Kruip, J., Sendak, R., Do Kwon, Y., Zhou, T., Chen, X Tags: Immunology, Medicine, Diseases, Virology r-articles Source Type: news

Male hormones may promote infection by virus that causes Kaposi's sarcoma
(PLOS) Male hormones may facilitate infection with a virus that can cause a type of cancer known as Kaposi's sarcoma. This finding, published in PLOS Pathogens by Ke Lan's group of the State Key Laboratory of Virology, Wuhan University, China, could help explain why men have an increased risk of developing Kaposi's sarcoma. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 28, 2017 Category: Infectious Diseases Source Type: news

Why is the flu vaccine so mediocre?
(Source: ScienceNOW)
Source: ScienceNOW - September 21, 2017 Category: Science Authors: Cohen, J. Tags: Immunology, Medicine, Diseases, Pharmacology, Toxicology, Virology In Depth Source Type: news

Hepatitis E: Virology, Epidemiology, Presentation and Therapy Hepatitis E: Virology, Epidemiology, Presentation and Therapy
What is our current understanding of the molecular biology of hepatitis E? Review diagnostic and therapeutic strategies and examine future directions for clinical research in this overview.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Where has all the Zika gone?
(Source: ScienceNOW)
Source: ScienceNOW - August 17, 2017 Category: Science Authors: Cohen, J. Tags: Epidemiology, Virology In Depth Source Type: news

On the trail of yellow fever
(Source: ScienceNOW)
Source: ScienceNOW - August 17, 2017 Category: Science Authors: Kean, S. Tags: Epidemiology, Pharmacology, Toxicology, Virology Feature Source Type: news

Newly Approved Hepatitis C Drug Has High Response Rates (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Nearly all patients with chronic hepatitis C virus (HCV) infection treated with glecaprevir-pibrentasvir achieved sustained virologic response after 12 weeks … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 16, 2017 Category: Primary Care Source Type: news

Einstein Researchers Awarded Three NIH Grants Totaling $12 Million to Fight Virulent Viruses
August 11, 2017—BRONX, NY—The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses—Ebola, Marburg and hantavirus. Research collaborations betweenKartik Chandran, Ph.D., professor of microbiology& immunology and the Harold and Muriel Block Faculty Scholar in Virology, andJonathan Lai, Ph.D., associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments. (Source: Einstein News)
Source: Einstein News - August 11, 2017 Category: Universities & Medical Training Source Type: news

Einstein researchers awarded 3 NIH grants totaling $12 million to fight virulent viruses
(Albert Einstein College of Medicine) The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses -- Ebola, Marburg and hantavirus. Research collaborations between Kartik Chandran, Ph.D., professor of microbiology& immunology and the Harold and Muriel Block Faculty Scholar in Virology, and Jonathan Lai, Ph.D. associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 11, 2017 Category: International Medicine & Public Health Source Type: news

Study Tracks Gender Ratios at Conferences
While men make up the majority of invited speakers at four major virology conferences, recent trends demonstrate a greater inclusion of women. (Source: The Scientist)
Source: The Scientist - July 31, 2017 Category: Science Tags: Daily News,News & Opinion,The Scientist Source Type: news

Should we be worried about hepatitis E?
(Stellenbosch University) Hepatitis E gets little press compared to its better-known cousins A, B and C, but Stellenbosch University virologists say we should wake up to how transmission of this virus is changing. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 27, 2017 Category: Infectious Diseases Source Type: news

Disease sleuths unmask deadly encephalitis culprit
(Source: ScienceNOW)
Source: ScienceNOW - July 27, 2017 Category: Science Authors: Pulla, P. Tags: Asia/Pacific News, Epidemiology, Medicine, Diseases, Virology In Depth Source Type: news

Zika rewrites maternal immunization ethics
(Source: ScienceNOW)
Source: ScienceNOW - July 20, 2017 Category: Science Authors: Cohen, J. Tags: Medicine, Diseases, Pharmacology, Toxicology, Science and Policy, Virology In Depth Source Type: news

Labmade smallpox is possible, study shows
(Source: ScienceNOW)
Source: ScienceNOW - July 13, 2017 Category: Science Authors: Kupferschmidt, K. Tags: Pharmacology, Toxicology, Science and Policy, Virology In Depth Source Type: news

New York City rats provide a gift to virologists
(Source: ScienceNOW)
Source: ScienceNOW - July 13, 2017 Category: Science Authors: Kiberstis, P. A. Tags: Immunology, Microbiology twis Source Type: news

Virological Testing for Early Infant HIV Diagnosis Virological Testing for Early Infant HIV Diagnosis
How accurate are virological assays for the diagnosis of HIV infection in infants?JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2017 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Sustained Response to Direct-acting HCV Antivirals Tied to Lower HCC Risk Sustained Response to Direct-acting HCV Antivirals Tied to Lower HCC Risk
A sustained virologic response to direct-acting antiviral treatment of hepatitis C (HCV) is associated with a “ considerable ” reduction in the risk of hepatocellular carcinoma (HCC), researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Sequential Sterilization of Simple Effluent Biowaste Streams
The AutoFlow SINK was designed for small laboratory applications such as research, virology, vaccines, and genetically modified organisms (GMO) in contract research organisations (CMO), hospitals, clinics, isolation units, and mobile laboratories. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 24, 2017 Category: Pharmaceuticals Source Type: news

By far, men garner most coveted speaking slots at virology meetings
(University of Wisconsin-Madison) In their recent study, published in the Journal of Virology, the University of Wisconsin-Madison researchers examined 35 years worth of invited speaker rosters from four prominent virology meetings, including the American Society for Virology, which is hosting its annual meeting in Madison, Wisconsin starting June 24, 2017. They found that men were overwhelmingly represented. For example, between 1982 and 2017, 77 percent of the speakers at ASV's annual meetings were male. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 23, 2017 Category: Biology Source Type: news

Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 and 2
Aptima HSV 1 & 2 Assay Now Available Alongside Women's Health, Virology Menu on the Fully Automated Panther System MARLBOROUGH, Mass. , June 20, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has ... Diagnostics, FDA Hologic, Aptima, Herpes Simplex Virus, Panther (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

Antiviral therapy is effective in fighting hepatitis C | Letters
The Cochrane analysis casting doubt on this life-saving therapy is flawed and may deter patients from seeking it, say clinicians and scientistsWe are clinicians and scientists who have studied and treated patients with chronic hepatitis C virus infection over many years and patient groups that represent those affected by hepatitis C. We write in response to your article on the effectiveness of antiviral therapy (Hepatitis ‘wonder drug’ may be clinically ineffective, say experts, 9 June). The Cochrane review that you highlight analysed clinical trials, which are by nature short term, where the sole purpose was t...
Source: Guardian Unlimited Science - June 13, 2017 Category: Science Authors: Letters Tags: Hepatitis C Health Pharmaceuticals industry Medical research Drugs Business Science UK news Society Source Type: news